Cell Therapy News Volume 10.34 | Aug 31 2009

    0
    26
    Cell Therapy News 10.34, August 31, 2009
         In this issue: Science | Policy | Business | NIH | CBER | Regulatory
    Cell Therapy News on Facebook  Cell Therapy News on Twitter

    Top Stories

    One Factor is Sufficient – Even in Human Cells: After successful experiments with murine cells, German researchers have now reprogrammed human somatic cells with a single factor. [Max Planck Institute for Molecular Biomedicine, Munster]
    Article

    Science

    Cord Blood Proficiency Testing: Standardize your Hematopoietic Colony-forming Cell (CFC) Assays with the PT Program.
    Link

    Wisconsin Team Grows Retina Cells from Skin-derived Stem Cells
    A team of scientists has successfully grown multiple types of retina cells from two types of stem cells — suggesting a future in which damaged retinas could be repaired by cells grown from the patient’s own skin. [University of Wisconsin-Madison, Madison]
    Article

    Finnish Scientists Discover Nerve Growth Factor with Possible Therapeutic Potential in Parkinson’s Disease
    Researchers report that their latest results show a certain growth factor can be used to halt the progress of damage brought on by a nerve poison and possibly even restore the function of damaged cells. [Academy of Finland, Helsinki]
    Article

    ‘Glow in the dark’ Red Blood Cells Made from Human Stem Cells
    Victorian stem cell scientists from Monash University have modified a human embryonic stem cell line to glow red when the stem cells become red blood cells. [Monash University, Victoria]
    Article

    Improvement of Liver Stem Cell Engraftment by Protein Delivery
    European researchers have engineered a chimeric protein that increases cell survival, migration and proliferation to improve stem cell engraftment. [INSERM, Paris]
    Article

    BrainStorm Cell Therapeutics Secures Funding to Reach Clinical Trials for ALS
    BrainStorm Cell Therapeutics Inc. announced recently that the company has secured the funding required to complete pre-clinical trials underway for the treatment of Amyotrophic Lateral Sclerosis. [BrainStorm Cell Therapeutics, New York]
    Article

    Scientists Develop Gene Therapy Method to Prevent Some Inherited Diseases
    Researchers believe they have developed one of the first forms of genetic therapy – a therapy aimed at preventing serious diseases in unborn children through mutated DNA in cell mitochondria. [Oregon Health and Science University, Portland]
    Article

    ABSTRACTS, REVIEWS AND SPECIAL REPORTS

    Repopulation Efficiencies of Adult Hepatocytes, Fetal Liver Progenitor Cells, and Embryonic Stem Cell-Derived Hepatic Cells in Albumin-Promoter-Enhancer Urokinase-Type Plasminogen Activator Mice
    This study explores the relative capacity of fetal liver progenitor cell suspensions and hepatic precursor cells derived from embryonic stem cells to engraft and repopulate a recipient liver compared with adult hepatocytes. [The American Journal of Pathology]
    Article

    Regeneration of Intestinal Stem/Progenitor Cells Following Doxorubicin Treatment of Mice
    Here, the researchers investigated the factors involved with the rapid turnover of cells fed by a hierarchy of transit amplifying and stem/progenitor cells destined to give rise to the four differentiated epithelial lineages of the small intestine. [American Journal of Physiology – Gastrointestinal Liver Physiology]
    Article

    NFI-A Directs the Fate of Hematopoietic Progenitors to the Erythroid or Granulocytic Lineage and Controls {Beta}-globin and G-CSF Receptor Expression
    This paper shows that in normal human hematopoiesis the transcription factor nuclear factor I-A exhibits a marked lineage-specific expression pattern: it is upmodulated in the erythroid lineage while fully suppressed in the granulopoietic series. [Blood]
    Article

    Definitive Proof for Direct Reprogramming of Hematopoietic Cells to Pluripotency
    This paper shows definitive proof of direct reprogramming of murine hematopoietic cells with no rearranged genes. [Blood]
    Article

    Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.

    JOB OPPORTUNITIES

    Research and Development Scientist – Stem Cell Biology

    Recruit Top Talent
    Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
    Visit here to post your career opportunities.

    Policy

    New York Commits $20.4M to Stem Cell Research
    Governor David Paterson said $5.4 million would earmarked to recruit research fellows and transition them into research institutions in New York.
    Article

    Business

    Connexon Creative Launches Cord Blood News
    Cord Blood News is a weekly e-newsletter that keeps members of the cord blood community informed by providing the latest news from all areas of the field, including its science, research, policy, and business.
    Link

    Geron Comments on FDA Hold on Spinal Cord Injury Trial
    Geron Corporation recently provided additional comments on the recent clinical hold on its Spinal Cord Injury Investigational New Drug. [Geron, Menlo Park]
    Article

    Mesoblast Limited US Associate Company Angioblast Closes A$10 Million Equity-Based Financing
    Mesoblast Limited recently announced that its United States-based associate company Angioblast Systems Inc. has closed a A$10 million equity-based financing from institutional and sophisticated investors. [Mesoblast Limited, Melbourne]
    Article

    Stem Cell Firm Plans Russia’s 1st Post-crisis Initial Public Offering
    Russia’s Stem Cell Institute is seeking to attract some 150 million rubles ($4.75 million) from investors in what would be the country’s first initial public offering in more than a year. [The Stem Cell Institute, Moscow]
    Article

    Drug, Biotech Research Spending Hangs Tough
    Corporate America’s research spending shrank 4% overall, or $1.9 billion, from the fourth quarter of 2007 through the second quarter of this year, according to data compiled by Capital IQ on 961 U.S. companies. But many health-care companies have boosted their research outlays.
    Article

    MOLOGEN Obtains US Patent for Cancer Treatment with Cell-based Gene Therapy
    The patent office in the USA has decided to grant MOLOGEN AG the patent for cell-based gene therapy to treat cancer. [MOLOGEN, Berlin]
    Article

    Indicted Scientist Still Confident of Cloning Authentic Stem Cells
    Disgraced cloning scientist Hwang Woo-suk seems to have returned to his old ways.
    Article

    NIH

    New Reporting and Assurance Requirements for Institutions Receiving Awards for Training of Graduate Students for Doctoral Degrees (NOT-OD-09-141)
    Link

    Two Critical Issues for Recent Submissions of Applications for Ruth L. Kirschstein National Research Service Awards (NRSA) Individual Fellowships References and Designation of Sponsor (NOT-OD-09-144)
    Link

    xTrain Expands to Include Use for NIH Institutional Career Development Awards and NLM Training Grants (NOT-OD-09-146)
    Link

    2010 NIH Directors New Innovator Award Program (DP2) (RFA-RM-09-011)
    Link

    Institutional Clinical and Translational Science Award (U54) (RFA-RM-09-019)
    Link

    Regulatory

    FOOD AND DRUG ADMINISTRATION (United States)

    Announcement of Office of Management and Budget Approval; Guidance for Industry on Formal Dispute Resolution; Appeals Above the Division Level
    Link

    Food and Drug Administration Transparency Task Force; Reopening of Comment Period until November 6, 2009
    Link

    Office of the Commissioner Reorganization; Statement of Organizations, Functions, and Delegations of Authority
    Link


     Learn more about Cell Therapy News:  Archives  |  Events  |  Update Profile  |  Contact Us